logo-loader

Morning Report: Scancell receives US approval for its SCIB1 skin cancer treatment

Headlines from the Proactive UK newsroom.

Scancell (LON:SCLP) has received IND approval from the US FDA for its SCIB1 skin cancer treatment. the company will now start a US Phase 2 trial in combination with leading drug Keytruda to see if it reduces toxicity compared to other pairings. 

Eco Atlantic (LON:ECO) has reported a 29% increase in the estimate for the amount of oil contained at its Orinduik Block, offshore Guyana. Gross prospective resources are now estimated at 5.14billion barrels on a best basis of which 771mln is net to Eco.

ADM Energy (LON:ADME) has signed a non-binding MOU with leading oil trading group Trafigura to look for opportunities in the African oil sector. ADM will act as the sponsor for opportunities to be presented to Trafigura either as a partner or where it can provide finance.

Chinese markets tumbled as they opened after the Lunar New Year holiday on fears of the impart of coronavirus. The Shanghai Composite index fell nearly 9% before rallying however healthcare shares soared.

Tobacco group Imperial Brands has appointed Stefan Bomhard as its new chief executive. Bomhard joins from Inchcape where he has been CEO for five years.

Digital magazine publisher Future continues to power ahead. Strong organic revenue growth and higher margins means results this year will be materially ahead of current market expectations.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Scancell Holdings PLC named herein, including the promotion by the Company of Scancell Holdings PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

OKYO Pharma appoints top Beverly Hills surgeon to lead its Scientific...

Dr James Khodabakhsh MD speaks to Proactive's Andrew Scott following his appointment as chair of OKYO Pharma's (LON:OKYO) Scientific Advisory Board. He'll be tasked with bringing together a small group of leaders to review and inform the company's plans to progress its lead product candidate...

3 hours, 13 minutes ago

2 min read